Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.36
-0.18 (-3.25%)
Sep 29, 2025, 3:19 PM EDT - Market open
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $294.24 million as of September 29, 2025. Its market cap has increased by 39.16% in one year.
Market Cap
294.24M
Enterprise Value
200.24M
1-Year Change
39.16%
Ranking
Category
Stock Price
$5.36
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $294.24M, an increase of 32.31%. That is a compound annual growth rate of 6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 304.12M | -17.51% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.68B |
| Johnson & Johnson | 435.52B |
| AbbVie | 391.05B |
| UnitedHealth Group | 311.48B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 231.01B |
| AstraZeneca | 228.75B |